Preclinical models detailed in the journal Nature Communications have shown that the jab against the avian influenza virus H5N1 is highly effective in preventing severe disease and death.Researchers at the University of Pennsylvania said the vaccine could potentially help control outbreaks of...
New Delhi: Emcure Pharmaceuticals Ltd and its arm Gennova Biopharmaceutical have settled all legal disputes with HDT Bio Corp and signed a long-term agreement to develop mRNA vaccines, the company said on Thursday.Under the agreement, the litigation between them, including the US court and the...
KUALA LUMPUR: Clinical trials of an mRNA vaccine have begun and researchers are expecting broadly positive results in the fight against the widespread disease.Influenza kills 650,000 people worldwide each year.According to the World Health Organization, ninety-nine percent of deaths in...
Melbourne, The field of RNA therapeutics has expanded incredibly over the past 30 years, and mRNA-based COVID-19 vaccines are just the beginning.It was a case of perfect timing.Scientists had been researching how to use RNA for medical purposes for more than 40 years when the COVID-19...
Data and analytics company GlobalData reports as part of World Immunization Week that around 507 prophylactic or preventative vaccines are currently in late-stage development, of which 88 are being developed using mRNA technology to Diseases can be prevented. From tuberculosis malaria to...